TLX News: Telix Collaboration on Next Generation Urologic-Oncology Theranostic Published in Journal of Nuclear - 15th Feb 2023, 7:51am

[annb0t]

MELBOURNE, Australia, Feb. 15, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces the successful completion of its joint research project conducted with Heidelberg University Hospital (UKHD) under the Research Cooperation Agreement announced in February 2021.[1] The aim of this project was to create and validate a generator-based theranostic compound for urologic oncology targeting PSMA[2] and utilising the beta-emitting isotope rhenium-188 (188R...

>>> Read more: Telix Collaboration on Next Generation Urologic-Oncology Theranostic Published in Journal of Nuclear Medicine